Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, et al.
Blood (2013) Vol. 122, Iss. 22, pp. 3616-3627
Open Access | Times Cited: 1711

Showing 1-25 of 1711 citing articles:

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2016) Vol. 127, Iss. 20, pp. 2391-2405
Open Access | Times Cited: 9112
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner, Elihu H. Estey, David Grimwade, et al.
Blood (2016) Vol. 129, Iss. 4, pp. 424-447
Open Access | Times Cited: 5146
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, et al.
New England Journal of Medicine (2014) Vol. 371, Iss. 26, pp. 2488-2498
Open Access | Times Cited: 4106
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, et al.
New England Journal of Medicine (2016) Vol. 374, Iss. 23, pp. 2209-2221
Open Access | Times Cited: 3536
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma, Rafael Bejar, Siddhartha Jaiswal, et al.
Blood (2015) Vol. 126, Iss. 1, pp. 9-16
Open Access | Times Cited: 1720
SomaticCALRMutations in Myeloproliferative Neoplasms with NonmutatedJAK2
Jyoti Nangalia, Charles Massie, E. Joanna Baxter, et al.
New England Journal of Medicine (2013) Vol. 369, Iss. 25, pp. 2391-2405
Open Access | Times Cited: 1647
High burden and pervasive positive selection of somatic mutations in normal human skin
Iñigo Martincorena, Amit Roshan, Moritz Gerstung, et al.
Science (2015) Vol. 348, Iss. 6237, pp. 880-886
Open Access | Times Cited: 1633
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian, et al.
Journal of the National Comprehensive Cancer Network (2018) Vol. 16, Iss. 3, pp. 310-320
Open Access | Times Cited: 1597
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
Torsten Haferlach, Yasunobu Nagata, Vera Grossmann, et al.
Leukemia (2013) Vol. 28, Iss. 2, pp. 241-247
Open Access | Times Cited: 1420
Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
Nicholas McGranahan, Charles Swanton
Cancer Cell (2015) Vol. 27, Iss. 1, pp. 15-26
Open Access | Times Cited: 1007
Mutations driving CLL and their evolution in progression and relapse
Dan A. Landau, Eugen Tausch, Amaro Taylor‐Weiner, et al.
Nature (2015) Vol. 526, Iss. 7574, pp. 525-530
Open Access | Times Cited: 982
The evolutionary history of 2,658 cancers
Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, et al.
Nature (2020) Vol. 578, Iss. 7793, pp. 122-128
Open Access | Times Cited: 909
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R. Coleman Lindsley, Brenton G. Mar, Emanuele Mazzola, et al.
Blood (2014) Vol. 125, Iss. 9, pp. 1367-1376
Open Access | Times Cited: 874
RNA in cancer
Gregory J. Goodall, Vihandha O. Wickramasinghe
Nature reviews. Cancer (2020) Vol. 21, Iss. 1, pp. 22-36
Closed Access | Times Cited: 837
Clonal hematopoiesis in human aging and disease
Siddhartha Jaiswal, Benjamin L. Ebert
Science (2019) Vol. 366, Iss. 6465
Open Access | Times Cited: 835
Mutational landscape and clonal architecture in grade II and III gliomas
Hiromichi Suzuki, Kosuke Aoki, Kenichi Chiba, et al.
Nature Genetics (2015) Vol. 47, Iss. 5, pp. 458-468
Closed Access | Times Cited: 771
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Lucy Yates, Moritz Gerstung, Stian Knappskog, et al.
Nature Medicine (2015) Vol. 21, Iss. 7, pp. 751-759
Open Access | Times Cited: 766
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
Andrew P. Feinberg, Michael A. Koldobskiy, Anita Göndör
Nature Reviews Genetics (2016) Vol. 17, Iss. 5, pp. 284-299
Open Access | Times Cited: 765
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
R. Coleman Lindsley, Wael Saber, Brenton G. Mar, et al.
New England Journal of Medicine (2017) Vol. 376, Iss. 6, pp. 536-547
Open Access | Times Cited: 682
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan, Francesco Favero, Elza C. de Bruin, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 283
Open Access | Times Cited: 649
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge, Eun Hee Kim, Omar Abdel‐Wahab, et al.
Nature reviews. Cancer (2016) Vol. 16, Iss. 7, pp. 413-430
Open Access | Times Cited: 603
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling, Christopher J. Gibson, Benjamin L. Ebert
Nature reviews. Cancer (2016) Vol. 17, Iss. 1, pp. 5-19
Open Access | Times Cited: 603
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg, Axel Karow, Ronny Nienhold, et al.
Blood (2014) Vol. 123, Iss. 14, pp. 2220-2228
Open Access | Times Cited: 577
Effect of Mutation Order on Myeloproliferative Neoplasms
Christina A. Ortmann, David G. Kent, Jyoti Nangalia, et al.
New England Journal of Medicine (2015) Vol. 372, Iss. 7, pp. 601-612
Open Access | Times Cited: 533
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Elsa Bernard, Heinz Tuechler, Peter L. Greenberg, et al.
NEJM Evidence (2022) Vol. 1, Iss. 7
Closed Access | Times Cited: 532
Page 1 - Next Page

Scroll to top